Search clinical trials for: Enteric-coated mycophenolate sodium (Myfortic)

Total 2505 results

Hamad Medical Corporation

Completed

An Investigation Into The Impact Of Enteric Coated Of Aspirin In Patients With Newly Diagnosed Ischemic Stroke. (ECASIS)

Stroke, Ischemic

Qatar
Yong Seog Oh

Withdrawn

Beta-blocker vs. Ic Antiarrhythmic Drug for PVC

Premature Ventricular Complex

Korea, Republic of
University of Washington

Completed

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (SALS) (MX-ALS-001)

Sporadic Amyotrophic Lateral Sclerosis

United States
UCB Pharma

Completed

An Open-label Continuation Trial to Assess the Continued Efficacy and Safety of Ascending Doses of Lacosamide in Subjects With Chronic Refractory Neuropathic Pain

Chronic Refractory Neuropathic Pain

Germany
Bial - Portela C S.A.

Completed

Single-dose and Steady-state Pharmacokinetics of BIA 2-093 and Its Metabolites

Epilepsy

Germany
Bial - Portela C S.A.

Completed

Eslicarbazepine Acetate as Add-On Treatment to One Baseline Antiepileptic Drug (ESLADOBA)

Epilepsy

Portugal
UCB BIOSCIENCES GmbH

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

Healthy | Renal Impairment

Germany
National Taiwan University Hospital
Shin Kong Wu Ho-Su Memorial Hospital

Not yet recruiting

Empagliflozin in Heart Failure With Reduced Ejection Fraction and End Stage Renal Disease (EMPA-RRED)

Heart Failure With Reduced Ejection Fraction | End Stage Renal Disease on Dialysis
Second Affiliated Hospital, School of Medicine,...
University of California, Los Angeles; Tongji Hospital; Michigan State University and other collaborators

Unknown

Evaluation of the Efficacy and Safety of Lacosamide in Pediatric Patients With Epilepsy

Epilepsy

China
NYU Langone Health

Completed

Diagnostic Value and Safety of Flecainide Infusion Test in Brugada Syndrome

Brugada Syndrome | Arrhythmogenic Right Ventricular Cardiomyopathy

United States
UCB Pharma

Completed

A Study Designed to Test the Effectiveness and Safety of Treating Patients With Lacosamide for Migraine Prophylaxis (SP906)

Migraine

United States
UCB Pharma

Completed

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Epilepsy

France, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
Bial - Portela C S.A.

Completed

Safety and Efficacy of Eslicarbazepine Acetate as Adjunctive Therapy for Partial Seizures in Elderly Patients

Epilepsy

Spain, Bulgaria, Austria, Croatia, Czechia, France, Germany, Poland, Portugal, Romania
The Cleveland Clinic
UCB Pharma

Completed

Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy

Partial Epilepsy

United States
Bial - Portela C S.A.

Completed

An Open-label, Single-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093

Epilepsy

South Africa
UCB Pharma

Completed

Belgian Drug-utilization Study to Evaluate the Use of VIMPAT® as Adjunctive Treatment of Partial Onset Seizures in Subjects Aged 16 and Older

Seizures

Belgium
First Affiliated Hospital Xi'an Jiaotong University

Recruiting

The Effect of Late Na Current Blocker Mexiletine on Giant T-wave Electrical Alternans(STOP-TWA)

Giant T-wave Electrical Alternans

China
MEDA Pharma GmbH & Co. KG

Completed

To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation

Atrial Fibrillation

France
Academisch Ziekenhuis Maastricht

Completed

Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy

Small Fiber Neuropathy

Netherlands
Scandinavian Critical Care Trials Group
Aarhus University Hospital; Rigshospitalet, Denmark; University of Copenhagen; Copenhagen...

Completed

Hydrocortisone for COVID-19 and Severe Hypoxia (COVID STEROID)

Covid-19 | Hypoxia

Denmark
Washington University School of Medicine
National Cancer Institute (NCI); National Institutes of Health (NIH); ImmunityBio... and other collaborators

Recruiting

Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

Acute Myeloid Leukemia

United States
Hospital for Special Surgery, New York

Recruiting

Intralipid® 20% for Reversal of Local Anesthetics

Anesthesia, Local

United States
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis

Cholestasis, Intrahepatic

Russian Federation
PLx Pharma

Completed

Pharmacodynamic and Pharmacokinetic Study of PL-ASA

Healthy Volunteers

United States
Vanderbilt University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Aspirin Resistance in Coronary Artery Disease

Coronary Artery Disease

United States
PLx Pharma

Completed

Pharmacodynamic Evaluation of PL2200 Versus Enteric-Coated Aspirin in Diabetic Patients (RITE)

Diabetes Mellitus, Type 2

United States
Lupin Ltd.

Recruiting

Open Label Study in Adolescents and Children With Myotonic Disorders

Myotonic Dystrophy

France
Lupin Ltd.

Active, not recruiting

An Observational Study in Adult Patients With Non-dystrophic Myotonic Disorders

Myotonic Dystrophy

France, Germany, United Kingdom
Lupin Ltd.

Active, not recruiting

Open-label Extension Study in Paediatric Patients Who Have Completed the MEX-NM-301 Study.

Myotonic Disorders

France
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Flecainide in Treating Patients With Chronic Neuropathic Pain

Pain

United States
Centre Hospitalier Saint Joseph Saint Luc de Lyon

Unknown

ZEBinix® Retention Rate in Epilepsy in Elderly Patients (ZEBRE)

Epilepsy | Aging | Epilepsy; Seizure | Aging Disorder

France
Bial - Portela C S.A.

Completed

Efficacy and Safety of Eslicarbazepine Acetate as Adjunctive Therapy for Refractory Partial Seizures

Refractory Partial Epilepsy

Portugal
Samsung Medical Center

Completed

Efficacy of Propafenone Versus Dronedarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation

Atrial Fibrillation

Korea, Republic of
UCB Pharma

Completed

An Open-label follow-on Trial to Assess the Long-term Safety and Efficacy of Oral SPM 927 in Subjects With Diabetic Neuropathy

Painful Diabetic Neuropathy
UCB Pharma

Completed

Study to Investigate Lacosamide as Add-on Therapy in Subjects ≥4 Years to <17 Years of Age With Partial Onset Seizures

Epilepsy

United States, Argentina, Australia, Belgium, Bulgaria, Colombia, Croatia, Czechia, Estonia, Georgia, Hungary, Israel, Italy, Korea, Republic of, Latvia, Lithuania, Mexico, Montenegro, Poland, Romania, Russian Federation, Serbia, Sl... and more
Eisai Inc.

Completed

A Post-marketing Study Evaluating Eslicarbazepine Acetate (ESL) as Adjunctive Treatment in Partial-Onset Seizures (Study E2093-E044-404) (EPOS)

Partial Onset Seizures

France, United Kingdom, Germany, Denmark, Czech Republic, Norway, Sweden, Ireland
UCB Pharma

Completed

Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males

Healthy Volunteers

Netherlands
Universitätsklinikum Hamburg-Eppendorf

Withdrawn

Investigation of Gender Specificity of the Effects of Furosemide in Healthy Female and Male Volunteers

Healthy Male and Female Volunteers

Germany
UCB Pharma

Completed

A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).

Postherpetic Neuralgia
University of Washington
Massachusetts General Hospital

Completed

Mexiletine in Sporadic Amyotrophic Lateral Sclerosis (Mexiletine-2)

Sporadic Amyotrophic Lateral Sclerosis

United States
UCB Pharma

Completed

eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (VERVE)

Epilepsy

United States, Australia, Bulgaria, Denmark, France, Germany, Romania, Spain, Sweden
Bial - Portela C S.A.

Completed

A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093

Epilepsy

Portugal
Ronaldo de Matos Esmeraldo, MD
Novartis Pharmaceuticals

Completed

Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

Cytomegalovirus Infections | Transplantation Infection

Brazil
University of Illinois at Urbana-Champaign
Federal Emergency Management Agency

Completed

Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting

Cardiovascular Risk Factor | C.Medical Procedure; Vascular, Functional or Late | Electrolyte and Fluid Balance Conditions

United States
Boryung Pharmaceutical Co., Ltd
Seoul National University Bundang Hospital; Cheil General Hospital and Women... and other collaborators

Completed

Administration Time-dependent Antihypertensive Effects of Low Dose Aspirin in Well-controlled Hypertensive Patients

Well-controlled Hypertension

Korea, Republic of
Overseas Pharmaceuticals, Ltd.
Beijing Capton Pharmaceutical Technology Development Co., LTD

Not yet recruiting

An Open Label, Balanced, Randomized, Two-Treatment, Two-Period, Two-Sequence, Two-way Crossover, Oralcomparative Pharmacokinetic（PK）Study of Lacosamide Extended-Release Tablets , Adult, Human Subjects Under Fasting Conditions.

Epilepsy

China
Ottawa Hospital Research Institute

Recruiting

RAFF4 Trial: Vernakalant vs. Procainamide for Acute Atrial Fibrillation in the Emergency Department

Atrial Fibrillation

Canada
Assistance Publique - Hôpitaux de Paris
Fonds de Dotation ACTION

Active, not recruiting

Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia (AFLOAT)

Patent Foramen Ovale | Cryptogenic Stroke | Atrial Arrhythmia

France
David Filgueiras-Rama
Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III

Completed

Predictive Factors to Effectively Terminate Paroxysmal Atrial Fibrillation by Blocking Atrial Selective Ionic Currents (SELECTCARFAP)

Paroxysmal Atrial Fibrillation

Spain
Daiichi Sankyo, Inc.

Completed

Relative Bioavailability DS-1971a Suspension and Tablets and Food Effect on DS-1971a Tablets

Healthy

United Kingdom

Search clinical trials for: Enteric-coated mycophenolate sodium (Myfortic)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations